OCE Insights
Update on Project Facilitate at the Oncology Center of Excellence
Mitchell Chan, PharmD, BCPS; Tamy Kim, PharmD; Jessica Boehmer, MBA; and Richard Pazdur, MD
OCE Insights is an occasional department developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Mitchell Chan, PharmD, BCPS, Regulatory Project Manager; Tamy Kim, PharmD, Associate Director of Regulatory ...
Patient-Centered Initiatives at the FDA
The ASCO Post Staff
OCE Insights is a periodic column developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this first installment, Vishal Bhatnagar, MD, Acting Associate Director of Patient Outcomes; Bellinda King-Kallimanis, PhD, Senior St...
This Year’s FDA-ASCO Workshop Focused on Collection of Patient-Reported Tolerability Data From Clinical Trials
Vishal Bhatnagar, MD; Bellinda King-Kallimanis, PhD; Paul Kluetz, MD; Heidi Klepin, MD; and Kathryn Mileham, MD
OCE Insights is an occasional column developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Vishal Bhatnagar, MD, Associate Director for Patient Outcomes, Bellinda King-Kallimanis, PhD, Senior Staff Fello...
Project Socrates: An Educational Bridge From the FDA to the Public
Jennifer J. Gao, MD, and Richard Pazdur, MD
OCE Insights is an occasional department developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Jennifer J. Gao, MD, Acting Associate Director of Education in the OCE, and Richard Pazdur, MD, Director of ...
